Thomas Burkart

CERAMIDE-GALACTOSYLTRANSFERASE AND CEREBROSIDE-SULPHOTRANSFERASE LOCALISATION IN GOLGI MEMBRANES ISOLATED BY A CONTINUOUS SUCROSE GRADIENT OF MOUSE BRAIN MICROSOMES

Abstract— A 17,000 g supernatant of mouse brain microsomes was subfractionated on a continuous sucrose gradient in order to localise ceramide galactosyltransferase (CGalt, EC 2.4.1.47) and cerebroside sulphotransferase (CST, EC 2.8.2.11), both enzymes involved in the synthesis of myelin lipids. The submicrosomal fractions were analysed for marker enzymes of myelin, plasma membranes, Golgi membranes, endoplasmic reticulum and lysosomes, and their protein distribution was studied. The results and EM studies give evidence that CGalT and CST are located in the Golgi membranes of the brain.

Influence of lipids on the activity of cerebroside- -sulphotransferase in mouse brain. A comparative study of jimpy and normal mouse brains.

Abstract— The effect of lipids other than the substrate cerebroside on the activity of cerebroside‐sulphotransferase (CST) in Jimpy and normal mouse brain was investigated.

Quantitative measurement of in vivo sulfatide metabolism during development of the mouse brain: Evidence for a large rapidly degradable sulfatide pool

The in vivo metabolism of sulfatide was studied in the cerebellum and in the cerebrum of developing mice by intraperitoneal injection of [ 35 S]sulfate. After correction for the specific radioactivity of the sulfate, total sulfatide synthesis and degradation could be determined. The developmental patterns of synthesis and degradation of sulfatide in vivo were compared with the developmental activity patterns of the synthesizing enzyme cerebroside sulfotransferase (CST, EC 2.8.2.11), the degrading enzyme cerebroside sulfate sulfatase, measured as arylsulfatase A (ASA, EC 3.1.6.1), and the net sulfatide synthesis in both brain parts. During brain development, sulfatide synthesis per milligram of tissue was higher in the cerebellum than in the cerebrum. Its developmental pattern was similar but not identical to the CST activity in vitro . The in vivo pattern of sulfatide degradation followed that of sulfatide biosynthesis and was similar to the developmental activity pattern of ASA. During myelination 40–70% of the newly synthesized sulfatide was degraded within 24 hr, as measured in two ways: (1) by a 24-hr chase of the [ 25 S]sulfatide and (2) by calculating the difference between the total daily sulfatide synthesis and net daily accumulation of sulfatide. Both methods of determination gave similar results. The data presented show that the synthetic enzyme CST is fully active in vivo , producing more sulfatide than is necessary for incorporation into myelin. The resulting sulfatide excess is rapidly degraded in the lysosomes by the action of ASA. Thus net sulfatide synthesis is partly regulated by lysosomal degradation during myelination of the brain.

Subcellular distribution of the antidepressant drug desipramine in cultured human fibroblasts after chronic administration. Drug-effect on the subcellular distribution of accumulated phospholipids.

Desipramine (DMI) is an important antidepressant drug and a lysosomotropic substance. In cultured fibroblasts it interferes with lysosomal functions, e.g. phospholipid degradation. Chronic exposure of cells with DMI induces storage of phospholipids. Subcellular fractionations of cultured human fibroblasts that had been exposed to a short pulse of 3H-DMI showed accumulation of DMI in two acidic compartments, one of high density represented the lysosomes and one of much lower density may contain pinosomes. In chronically exposed cells DMI accumulated in the subcellular fractions of lower density only. DMI induced an important shift of lysosomal enzymes from vesicles of high density to the ones of lower density. Phospholipids were accumulating in those vesicles of lower density as well as in the fractions that contained plasma membranes. DMI also accumulated in one part of the Golgi vesicles of acute and chronically exposed cells. In the latter phospholipids and arylsulfatase A activity were also accumulating. DMI possibly interferes with membrane recycling. This eventually could induce changes in phospholipid content and composition in the plasma membrane which may have important implications for membrane functions.

Influence of reduced cholesterol synthesis on the activity of cerebroside sulfotransferase in cultured glioblastoma cells treated with estradiol.

Cultured glioblastoma cells were inoculated with estradiol in concentrations of 0.5--10 microliter/ml medium in order to check the effect of this hormone on the activity of cerebroside sulfotransferase, an enzyme whose activity is strongly related to myelination. Thereby we could show that the cerebroside-sulfotransferase activity increases to a value of 200% of normal. Concomitant to this effect, the cholesterol content of the membrane bearing cerebroside sulfotransferase activity decreases to 60% of normal. The effect is fully reversible: after 48 h, cholesterol synthesis as well as cerebroside sulfotransferase activity reach normal values again. We suggest that cerebroside sulfotransferase activity is modulated by the changing cholesterol/phospholipid ratio in the cells during the inoculation period.

Sulfated glycosaminoglycans (GAG) in the developing mouse brain: Quantitative aspects on the metabolism of total and individual sulfated GAG in vivo☆

Sulfation and desulfation of total glycosaminoglycans (GAG) as well as of chondroitin sulfates (A + C), dermatan sulfate, and heparan sulfate were quantified in the developing cerebrum and cerebellum of mice by labeling with [35S]sulfate combined with chases started 24 hr after [35S]sulfate injection. In both the developing cerebrum and cerebellum, the rate of biosynthesis of total sulfated GAG was highest shortly after birth (2 days), decreased sharply thereafter, and reached a plateau after 14 days. The biosynthetic activities of chondroitin sulfates and heparan sulfate decreased sharply up to 14 days and retained constant levels afterward. By contrast, the rates of biosynthesis of dermatan sulfate increased up to 14 days. The biodegradation rates of total sulfated GAG as well as of chondroitin sulfates, heparan sulfate, and dermatan sulfate were strongly correlated with the corresponding rates of biosynthesis during the first 2 postnatal weeks. Total and individual sulfated GAG showed high degradation rates resulting in half-life times of a few hours up to 1 1/2 days. Thus sulfated GAG are synthesized in excess and the actual net content seems to be co-regulated to a high degree by lysosomal degradation. In both brain parts, a proportional increase of the sulfated GAG content vs the total GAG content from 40% at birth to 90% at 28 days was observed. Since during development heparan sulfate and dermatan sulfate manifested a relative increase in their daily net synthesis besides a decrease of chondroitin sulfates, a developmental increase of the sulfate groups linked to GAG is evidenced. This molecular differentiation resulting in microenvironmental changes may be of high functional significance.

Metabolism of sulfogalactosyl glycerolipids in the myelinating mouse brain

The in vivo metabolism of sulfogalactosyl glycerolipids (SGG) was studied in the cerebrum and cerebellum of developing mice after intraperitoneal injection of [35S]sulfate. After correction for the specific radioactivity changes of blood sulfate the quantitative rates of biosynthesis and biodegradation of this lipid could be determined. In addition, the net accumulation of SGG was measured. Throughout development the rates of SGG biosynthesis and net accumulation were higher in the cerebellum than in the cerebrum. The developmental patterns of SGG net synthesis in both parts of the brain were closely related to those observed earlier for sulfatide. During development the rate of SGG biosynthesis in both parts of the brain showed a peak earlier than that of sulfatide (at 14 days versus 20 days). The in vivo patterns of SGG degradation followed those of biosynthesis in the cerebrum and cerebellum. During postnatal development 40 to 80% of the daily synthesized SGG disappeared within 24 hr, suggesting that degradation may also be involved in the regulation of SGG net synthesis during myelination, as previously indicated for sulfatide.

Theophylline Reduces the Activity of Cerebroside-Sulfotransferase, a Key Enzyme in Myelination, in Cell Cultures from Newborn Mouse Brain

Summary: Theophylline, a drug used in neonatology for the treatment of apnea, affects cholesterol synthesis if administered in concentrations of 10-4 M (a concentration found in serum of treated patients) for 24 hr to dissociated brain cell cultures. The rate-limiting enzyme of cholesterol synthesis, β-hydroxy-β-methylglutaryl-coenzyme A reductase (EC 1.1.1.34), is lowered to 45% 48 hr after removal of theophylline. At the same time, cholesterol content of the cells is lowered to 73%. Inasmuch as the phospholipid content of the cells remains stable, the treatment changes the cholesterol phospholipid ratio. Concomitant to this effect, the activity of cerebroside-sulfotransferase (EC 2.8.2.11) is lowered to 60% of control values. We postulate that these two effects are linked to each other by means of modulation of the cerebroside-sulfotransferase activity by membrane lipids.Speculation: Theophylline reduces cholesterol synthesis and content and by that cerebroside-sulfotransferase activity in dissociated brain cell cultures. This raises the question of whether theophylline could have similar effects in vivo.

Net sulfatide synthesis, galactosylceramide sulfotransferase and arylsulfatase a activity in the developing cerebrum and cerebellum of normal mice and myelin-deficient jimpy mice.

Net sulfatide synthesis, galactosylceramide sulfotransferase (EC 2.8.2.11) and arylsulfatase A (EC 3.1.6.1) activities were measured in two brain regions, cerebrum and cerebellum, of normal and jimpy mice during postnatal development. In normally myelinating mice, two phases of increasing rates of net sulfatide synthesis were observed, the first coinciding with oligodendrocyte proliferation and the second with myelination. Net sulfatide synthesis was quantitatively higher in the cerebellum than in the cerebrum. In both brain regions, the developmental patterns of net sulfatide synthesis were related to the activity patterns of both galactosylceramide sulfotransferase and arylsulfatase A. In jimpy mice, a neurological mutant showing hypomyelination in brain, the first phase of net sulfatide synthesis was preserved in both brain regions and galactosylceramide sulfotransferase and arylsulfatase A activities were normal up to 12 days. However, during the phase in which myelination occurred in controls, the net sulfatide synthesis in both brain regions of jimpy mice was zero or even negative. The sulfatide deficit was larger in the cerebellum than in the cerebrum. In both mutant brain parts, galactosylceramide sulfotransferase activity increased up to 12 days showing about 50% of the maximal activities observed in normal brain regions. Thereafter up to 15 days, enzyme activity decreased to about 25% of that of controls and remained low in both brain regions. The developmental patterns and the activities of arylsulfatase A were, however, normal in the cerebrum and cerebellum of jimpy mice. These results suggest that the enzyme activities and the developmental patterns of galactosylceramide sulfotransferase and arylsulfatase A as measured in vitro reflect to a high degree their functional activity in vivo. Furthermore, sulfatide degradation by arylsulfatase A seems to be important in regulating net sulfatide synthesis during normal and impaired myelination.

Synthesis and subcellular transport of sulfogalactosyl glycerolipids in the myelinating mouse brain

In the 17-day-old myelinating mouse brain the site of sulfogalactosyl glycerolipid synthesis and the kinetics of its subcellular distribution were studied by a 2 h pulse-labeling with [35S]sulfate followed by a 4 h chase of [35S]sulfogalactosyl glycerolipid. At several time intervals after the intraperitoneal [35S]sulfate injection, subcellular fractions of brain were obtained by differential and discontinuous sucrose gradient centrifugation. The crude microsomal membrane fraction (17 500 X g supernatant) was further subfractionated into light myelin, plasma membranes, Golgi vesicles, endoplasmic reticulum membranes and heavy vesicles associated with acid hydrolase activities. The results of the [35S]sulfogalactosyl glycerolipid labeling kinetics indicate that these lipids are synthesized in the Golgi-endoplasmic reticulum complex and transferred in vesicles associated with lysosomes to the myelin membranes. During this transfer part of the sulfogalactosyl glycerolipids appears to be degraded, similarly as described for brain sulfatides. This double function of lysosomes may be part of a general regulation mechanism of brain myelin glycolipid content.